COT drives resistance to RAF inhibition through MAP kinase pathway reactivation CM Johannessen, JS Boehm, SY Kim, SR Thomas, L Wardwell, ... Nature 468 (7326), 968-972, 2010 | 1756 | 2010 |
Characterizing the cancer genome in lung adenocarcinoma BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ... Nature 450 (7171), 893-898, 2007 | 1299 | 2007 |
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset CJ Ceol, Y Houvras, J Jane-Valbuena, S Bilodeau, DA Orlando, V Battisti, ... Nature 471 (7339), 513-517, 2011 | 633 | 2011 |
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition CM Johannessen, LA Johnson, F Piccioni, A Townes, DT Frederick, ... Nature 504 (7478), 138-142, 2013 | 497 | 2013 |
Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody H Haack, LA Johnson, CJ Fry, K Crosby, RD Polakiewicz, EB Stelow, ... The American journal of surgical pathology 33 (7), 984-991, 2009 | 419 | 2009 |
The role of SPINK1 in ETS rearrangement-negative prostate cancers SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ... Cancer cell 13 (6), 519-528, 2008 | 401 | 2008 |
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer SR Setlur, KD Mertz, Y Hoshida, F Demichelis, M Lupien, S Perner, ... Journal of the National Cancer Institute 100 (11), 815-825, 2008 | 395 | 2008 |
Recent insights into the structure, regulation, and function of the V-ATPases K Cotter, L Stransky, C McGuire, M Forgac Trends in biochemical sciences 40 (10), 611-622, 2015 | 375 | 2015 |
Integrative analysis of the melanoma transcriptome MF Berger, JZ Levin, K Vijayendran, A Sivachenko, X Adiconis, J Maguire, ... Genome research 20 (4), 413-427, 2010 | 347 | 2010 |
The function of V-ATPases in cancer L Stransky, K Cotter, M Forgac Physiological reviews 96 (3), 1071-1091, 2016 | 303 | 2016 |
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States JM Mosquera, R Mehra, MM Regan, S Perner, EM Genega, G Bueti, ... Clinical cancer research 15 (14), 4706-4711, 2009 | 292 | 2009 |
Amino acid availability modulates vacuolar H+-ATPase assembly LA Stransky, M Forgac Journal of Biological Chemistry 290 (45), 27360-27369, 2015 | 164 | 2015 |
An Oncogenic Role for ETV1 in Melanoma J Jané-Valbuena, HR Widlund, S Perner, LA Johnson, AC Dibner, WM Lin, ... Cancer research 70 (5), 2075-2084, 2010 | 135 | 2010 |
Clinical significance of TTF‐1 protein expression and TTF‐1 gene amplification in lung adenocarcinoma JA Barletta, S Perner, AJ Iafrate, BY Yeap, BA Weir, LA Johnson, ... Journal of cellular and molecular medicine 13 (8b), 1977-1986, 2009 | 127 | 2009 |
NUT midline carcinoma of the parotid gland with mesenchymal differentiation MA den Bakker, BH Beverloo, MM van den Heuvel-Eibrink, CA Meeuwis, ... The American journal of surgical pathology 33 (8), 1253-1258, 2009 | 112 | 2009 |
Amplification of chromosomal segment 4q12 in non-small cell lung cancer AH Ramos, A Dutt, C Mermel, S Perner, J Cho, CJ Lafargue, LA Johnson, ... Cancer biology & therapy 8 (21), 2042-2050, 2009 | 109 | 2009 |
Regulation of V-ATPase activity C McGuire, L Stransky, K Cotter, M Forgac Front Biosci (Landmark Ed) 22 (4), 609-622, 2017 | 86 | 2017 |
Regulation of V-ATPase assembly and function of V-ATPases in tumor cell invasiveness C McGuire, K Cotter, L Stransky, M Forgac Biochimica et Biophysica Acta (BBA)-Bioenergetics 1857 (8), 1213-1218, 2016 | 82 | 2016 |
HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss across species HE Nicholson, Z Tariq, BE Housden, RB Jennings, LA Stransky, ... Science signaling 12 (601), eaay0482, 2019 | 64 | 2019 |
AKT Ser/Thr kinase increases V-ATPase–dependent lysosomal acidification in response to amino acid starvation in mammalian cells MP Collins, LA Stransky, M Forgac Journal of Biological Chemistry 295 (28), 9433-9444, 2020 | 22 | 2020 |